Related Experiment Videos
[Neurospecific proteins in human malignant brain tumors].
Biulleten' Eksperimental'Noi Biologii I Meditsiny
|July 1, 1985
Summary
Measuring neurospecific proteins S-100, Glial Fibrillary Acidic Protein (GFA), and D2 in brain tumors aids diagnosis. Combined S-100 and GFA levels offer reliable histogenesis insights, with D2 protein serving as the most stable marker.
Area of Science:
- Neuroscience
- Oncology
- Biochemistry
Background:
- Malignant cerebral tumors present diagnostic challenges.
- Accurate histogenesis is crucial for effective treatment planning.
- Neurospecific proteins are potential biomarkers for brain tumors.
Purpose of the Study:
- To quantify neurospecific proteins S-100, Glial Fibrillary Acidic Protein (GFA), and D2 in malignant cerebral tumors.
- To evaluate the diagnostic utility of individual and combined proteins for tumor histogenesis.
- To identify the most stable specific protein marker for cerebral tumors.
Main Methods:
- Electrophoresis was employed to measure protein content.
- Monospecific antisera were utilized for precise protein detection.
- Quantification of S-100, GFA, and D2 proteins was performed.
Main Results:
- Concomitant measurement of S-100 and GFA proteins proved more reliable for determining tumor histogenesis than analyzing each protein individually.
- The D2 protein demonstrated the highest stability as a specific marker among the studied proteins.
- Differential expression patterns of these proteins were observed in malignant cerebral tumors.
Conclusions:
- Combined analysis of S-100 and GFA proteins enhances diagnostic accuracy for cerebral tumor histogenesis.
- D2 protein is a highly stable and specific biomarker for malignant cerebral tumors.
- These neurospecific proteins hold significant potential for improving the diagnosis and classification of brain tumors.